Disclosures for "Personalized Neuromodulation for Persistent Post-Concussive Symptoms: Preliminary Findings and Trial Protocol"
-
Dr. Bickart has nothing to disclose.
-
Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highmark Interactive. Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceutical. Dr. Giza has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lewitt, Hackman, Shapiro, Marshall & Harlan. Dr. Giza has received stock or an ownership interest from Highmark Interactive. The institution of Dr. Giza has received research support from NCAA. The institution of Dr. Giza has received research support from US Department of Defense. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care.
-
Dr. Leuchter has received personal compensation in the range of $0-$499 for serving as a Consultant for ElMinda. Dr. Leuchter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Options MD. Dr. Leuchter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eFovea.
-